D47.1 Chronic myeloproliferative disease

(Chronic myeloproliferative disease )

Rare males and females disease from the section "". Causes not a significant loss of workdays. Not mortally.

504 449 people were diagnosed with Chronic myeloproliferative disease

34 558 died with a diagnosis of Chronic myeloproliferative disease

0.07 % disease mortality Chronic myeloproliferative disease

Chronic myeloproliferative disease is diagnosed to men at 3.97% more often than women

257 139

Men are diagnosed with Chronic myeloproliferative disease. For 17 650 of them, this diagnosis is fatal

0.07 %

mortality in men with disease Chronic myeloproliferative disease

95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0

247 310

Women are diagnosed with Chronic myeloproliferative disease For 16 908 of these, this diagnosis is fatal.

0.07 %

mortality in women with disease Chronic myeloproliferative disease

Risk group for the disease Chronic myeloproliferative disease men aged 70-74 and women aged70-74

The disease is most common in men aged 70-74

In men, the disease is least likely to occur at the age of

In women, the disease is least likely to occur at the age of

The disease is most common in women aged 70-74

Features of the disease Chronic myeloproliferative disease

Absence or low individual and social danger

* - Medical statistics for the whole group of diseases D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

Diagnostics

Standard for diagnosing the disease Chronic myeloproliferative disease not found

Diagnosis Chronic myeloproliferative disease on the 1 place in the frequency of diseases in the rubric of other Neoplasms of uncertain or unknown behaviour diseases

Most common:

Chronic myeloproliferative disease disease on the 1 most dangerous disease in the category of other Neoplasms of uncertain or unknown behaviour diseases

Most dangerous:


* - Medical statistics for the whole group of diseases D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

Treatment

The standard for the treatment of the disease Chronic myeloproliferative disease is not is established

5 days required for doctors in inpatient treatment

7 hour(s) is required for outpatient treatment

0 medical procedures are provided for the treatment of Chronic myeloproliferative disease


* - Medical statistics for the whole group of diseases D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue

Diseases with similar symptoms

Single spontaneous delivery

Single spontaneous delivery ,

One of the most popular female diseases from the section "Delivery". Causes not a significant loss of workdays. Not mortally.

Low risk, only women get sick, age 13-57

Liveborn infants according to place of birth

Liveborn infants according to place of birth ,

One of the most popular males and females diseases from the section "Persons encountering health services in circumstances related to reproduction". Causes not a significant loss of workdays. Not mortally.

Low risk, sick men and women, age 0-0

Fall on same level from slipping, tripping and stumbling

Fall on same level from slipping, tripping and stumbling ,

One of the most popular males and females diseases from the section "Falls". Causes not a significant loss of workdays. May be the cause of death.

Medium risk, sick men and women, age 1-100

Heart failure

Heart failure ,

One of the most popular males and females diseases from the section "Other forms of heart disease". Causes not a significant loss of workdays. May be the cause of death.

High risk, sick men and women, any age

Possible Symptoms